Luke Scicluna

Immunologist/Neuroscientist who moved to the Biotechnology sector, interested in Life Science developments.
#Biotech #Pharma #Covid19 #SARS_CoV_2

[Medical Xpress @medical_xpress]

Highly potent, stable nanobodies stop SARS-CoV-2 https://t.co/IF1xmSG2b7

[Medical Xpress @medical_xpress]

New tool predicts sudden death in inflammatory #heart disease @johnshopkins @ScienceAdvances https://t.co/X06yzv4DwB

[Dr Timos Papagatsias @_timos_]

Lilly bets $70M upfront but squeezes in a major $2B in biobucks for Kumquat and its small-molecule immuno-oncology work https://t.co/KbAmzsQ6bt #strategy #competitiveintelligence #marketing #biotech #competitivemarketing #healthcare #pharma #pharmaceutical

[Biomedical Picture of the Day BPoD @BPoD_s]

Lab bone marrow model grown from patient #cells successfully tests how the individual will respond to #platelets-boosting treatments. Image and research by Christian A Di Buduo et al @ABalduiniLab @unipv in @eLife. Read more on https://t.co/2nV5sXmstL with @MRC_LMS and @esbriolat

[EMDB - EMPIAR @EBI @EMDB_EMPIAR]

Released @EMDB_EMPIAR & published @FrontiersIn, the wonderful #FIBSEM data set of Gemmata obscuriglobus; #Planctomycetes #Bacteria that have unique #Cell architectures with heavily invaginated #Membranes by Seeger et al. from @uppsalauni.
1/2

[Eric Topol @EricTopol]

New large study of mRNA vaccine effectiveness for people with prior Covid
"Among those vaccinated with BNT162b2, protection against infection was further enhanced and infection incidence was further reduced by prior infection"
https://t.co/P3c18iASrq

[World Health Organization (WHO) @WHO]

The #COVID19 virus continues to change and the Delta variant is more transmissible compared to the other virus strains. Listen to Dr @mvankerkhove share what is known so far about the delta variant and how we can keep ourselves safe ⬇️

[Nature Biotechnology @NatureBiotech]

High-throughput mapping of a whole rhesus monkey brain at micrometer resolution https://t.co/ODDG8ezqNb

[Eric Topol @EricTopol]

New @CellRepMed
The durable immune response to covid lasting at least 8 months, with memory B cells and polyfunctional T cells
https://t.co/pQ1J1XlcP8
@fredhutch @EmoryVaccineCtr

[gloglita @glogliiita]

And since it seems that my #sciartportfolioweek is getting a little bit gender biased, here a shoutout to this super brilliant #sciart animator.
I love the addition of more than the straight up #spike protein of #SARSCoV2

[Sten Rüdiger @StenRuediger]

So proud that our paper on contact networks and #SARSCoV2 in PNAS is now online. Summary coming up. https://t.co/TSlg21NjZn

[DiseaseOutbreak @DiseaseOutbreak]

Cumulative #DeltaVariant prevalence mapped around the world from https://t.co/lUtqfQZlir

And countries with a cumulative prevalence >5%. Note: bars indicate confidence intervals.

#B16172 #SARSCoV2

[Laurie Garrett @Laurie_Garrett]

Let's see, the first genomic sequence of #SARSCoV2 was posted 2nd week January 2020...19 months ago.
And NOW we're talking about standardizing diagnostic & surveillance tests?
HEY @US_FDA -- you awake?

[Anna Foix @FoixCli]

Agree with @MalloryFreeberg , cooperation in science will get us far 👩‍🔬👩‍💻 Check out how
@EGAarchive teamed up with amazing resources to enable important #COVID19 and #SARSCoV2 research over the past year 🙌

[NEJM @NEJM]

In the @NEJM Covid-19 Vaccine Resource Center, @PaulSaxMD provides concise and engaging answers to clinicians’ questions about Covid-19 vaccination and to the questions and concerns patients will raise. #SARSCoV2 #IDTwitter

[Vanderbilt Microbiome @VuBiome]

Daily number of tests for #SARSCoV2 #coronavirus:

[NEJM @NEJM]

In this study involving 2,380 vaccinated persons in a Rhode Island prison complex, there were 27 breakthrough cases of #COVID19, all of which were asymptomatic. Vaccination appeared to be safe and effective at preventing #SARSCoV2 transmission in a prison.

[Putra @realbolakentang]

Horoscopes and Blood types are overrated, what COVID variant are you? #SARSCoV2

[Inspira Pharmaceuticals @Inspira_pharma]

“The market for inhaled therapeutics is large and growing rapidly, with significant opportunities to address unmet needs.”

#SARSCoV2 #covid19 #treatments
https://t.co/iwdsTUs9U1

[Alvin @alvie_barr]

This is BIG! Low-Cost Biosensor for Minute-Scale Detection of #SARSCoV2

👉 Costs $1.50, takes 6.5 minutes, & demonstrates high accuracy; can facilitate high-frequency testing in resource-limited settings!

Link: https://t.co/rUgIb8EBhF

@delafuenteupenn @michaelmina_lab #COVID19